GlassScriptPhysician profile
Matthew Evans Snow
NPI 1609294115
$2,239.33
in general payments reported to CMS, 2019-2025
26 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $139 · 2021: $229 · 2022: $329 · 2023: $678 · 2024: $196 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $480.34 | 2020-2023 | Hoffmann, Prophecy, Mini Maxlock Extreme |
| Smith+Nephew, INC. | $217.38 | 2020-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Horizon Therapeutics Plc | $184.65 | 2019-2021 | |
| Abbvie INC. | $182.07 | 2022-2024 | Dalvance |
| Biotissue Holdings INC. | $149.03 | 2021-2024 | |
| Melinta Therapeutics, LLC | $143.08 | 2023-2025 | Kimyrsa |
| Kci USA, INC. | $129.98 | 2019-2023 | V.A.C. Veraflo, Activ.A.C. |
| Mimedx Group, INC. | $118.33 | 2024-2025 | |
| Kerecis Limited | $86.28 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $83.77 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Osiris Therapeutics INC. | $55.62 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $55.26 | 2025 | |
| Paratek Pharmaceuticals, INC. | $41.79 | 2020-2023 | Nuzyra |
| Abbott Laboratories | $40.10 | 2023 | Eterna |
| Polarityte, INC. | $38.96 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $35.18 | 2025 | Puraply Wound Matrix |
| Zimmer Biomet Holdings, INC. | $31.78 | 2019 | |
| Saxum Surgical, INC. | $27.02 | 2025 | |
| Treace Medical Concepts, INC. | $21.62 | 2023 | |
| Bioventus LLC | $21.16 | 2021 | |
| Bone Support INC. | $18.99 | 2025 | Cerament G, Ceramentbone Void Filler |
| Innovation Technologies INC | $18.90 | 2024 | Irrisept |
| Musculoskeletal Transplant Foundation INC. | $16.91 | 2019 | |
| Tactile Systems Technology INC | $14.86 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.30 | 2019 | |
| Zyla Life Sciences, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.